• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDEWIRE ADVANTAGE; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDEWIRE ADVANTAGE; WIRE, GUIDE, CATHETER Back to Search Results
Model Number RA*FA18301C
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Codes Blood Loss (2597); Device Embedded In Tissue or Plaque (3165)
Date of Event 07/22/2020
Type of Reportable Event Serious Injury
Event or Problem Description
The user facility reported that the involved radifocus glidewire advantage was used during the procedure.The doctor was utilizing the involved wire from the radial approach and crossing a right ostial iliac lesion.The wire crossed the lesion and a 4mm x 40mm armada balloon was advanced over the wire.However, the balloon did not cross the lesion.The physician decided to gain access in the right groin with a 7f 23cm bright tip cordis sheath and utilize a snare to grab the wire and pull through the sheath and out as to create a rail to advance the balloon over.While snaring the wire, the physician pulled hard and quickly, and advanced the sheath at the same time.This whipped the wire into the 7fr sheath and subsequently caused the balloon to shoot through the lesion and into the sheath as well.The balloon was across the lesion the doctor still could not inflate, due to it being in the distal end of the sheath.He retracted the balloon back out of the sheath; however, inadvertently pulled the wire back proximal to the lesion with the balloon.He then started to cross the ostial iliac lesion once again and as soon as he crossed the lesion the second time, he noticed loss of control of the wire and was not responding.He pulled the wire out of the patient and noted an approximate 10-15cm of the distal wire was still across the lesion.He tried for approximately 40 minutes to snare the wire although only a few mm was passed the lesion and could not easily be snared, the snaring equipment was not long enough to try from the radial approach.The physician made the decision to finish the procedure and stented both iliac with kissing stents jailing the broken wire segment into place.The outcome of the procedure was accomplished, and the physician was happy with his results of restored flow.The patient's condition was stable.The estimated blood loss was less than 250cc.There was no patient injury, medical/surgical intervention required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIFOCUS GLIDEWIRE ADVANTAGE
Common Device Name
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key10356080
Report Number2243441-2020-00046
Device Sequence Number2360230
Product Code DQX
UDI-Device Identifier04987350714763
UDI-Public04987350714763
Combination Product (Y/N)N
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/03/2020
Report Date (Section F) 08/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2021
Device Model NumberRA*FA18301C
Device Catalogue NumberGA1830
Device Lot Number191106
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date07/22/2020
Device Age8 MO
Event Location Hospital
Date Report to Manufacturer07/23/2020
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/03/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Date Report Sent to FDA08/03/2020
-
-